Hess Midstream Partners LP (HESM) signals a pivotal shift towards robust free cash flow generation, forecasting a 40% drop in capital expenditures for 2026 as its core system build-out concludes. Despite near-term weather headwinds, strong minimum volume commitments underpin financial targets through 2028.
Stifel Nicolaus lowered its price target on Altria Group (MO) by $4 to $68, citing higher-than-expected operating costs. Despite near-term headwinds, the firm reaffirmed its Buy rating, pointing to the tobacco giant's resilient dividend profile and long-term earnings guidance.
With the cost of living significantly higher than just a few years ago, Channel 11's Susan Koeppen offers actionable tips to help households reduce recurring bills and ease financial pressure.
A look back at 2016's recurring bills reveals a stark financial truth: small, consistent savings on expenses like cable, cell plans, or insurance, when invested, could have yielded a significant nest egg by today.
The probate process can drain an estate's assets and burden heirs for years. Financial and legal experts outline practical steps families can take now to ensure a smoother transfer of wealth.
While the online marketplace sector posted robust Q3 earnings, investor sentiment remains tepid. Shutterstock's strategic embrace of generative AI and solid financials were overshadowed by a broader sell-off, raising questions about valuation in a shifting digital landscape.
Takeda Pharmaceutical raises its FY2025 revenue and profit guidance following resilient nine-month results and announces U.S. availability of a new ready-to-use immunoglobulin therapy for primary immunodeficiency, fueling discussions on its growth strategy amid high debt and margin pressures.
Harmony Biosciences CFO Sandip Kapadia has liquidated his entire direct stake in the company, a move that contrasts sharply with the firm's robust financial performance and bullish $1 billion revenue target for its flagship drug WAKIX by 2026. While the sales were pre-planned, the timing fuels debate on insider confidence versus corporate optimism.
Facing declining core automotive revenue, Tesla announces a radical strategic shift, halting production of flagship luxury models to fund a massive push into robotics and autonomous vehicles. Investors are left weighing ambitious promises against a backdrop of financial strain.
Boston Scientific's latest earnings beat and raised guidance, fueled by strong demand for its electrophysiology devices, signal a strategic shift. The company is navigating tariff pressures while expanding margins, with major acquisitions poised to reshape its long-term profile.
Seagate Technology Holdings' stock surged following a strong fiscal Q2 report, fueled by robust demand from AI and data center markets. The company's revenue guidance and multi-year visibility for its advanced HAMR-based storage platform signal confidence in sustained growth, though execution risks remain.
Precious metals giant Fresnillo PLC has revised down its 2026 production targets for silver and gold, citing operational setbacks and revised mine plans. The guidance cut forces a fresh look at the company's valuation and near-term growth trajectory amid a volatile sector.
Financial technology firm Broadridge Financial Solutions prepares to release its fourth-quarter results before Tuesday's market open, with analysts projecting modest revenue growth against a backdrop of recent sector volatility.
As PJT Partners prepares to release its fourth-quarter results, the market watches to see if the elite advisory firm can continue its run of topping revenue estimates amidst a turbulent period for financial stocks.
Electronic Arts (EA) is set to report its fourth-quarter financial results after Tuesday's market close, with Wall Street anticipating a significant revenue rebound. The report comes at a pivotal moment for the gaming sector, which has faced mixed signals from consumers and a volatile market.
BellRing Brands prepares to release its fourth-quarter financial results, with analysts forecasting a revenue dip. The report comes as investors gauge the resilience of the shelf-stable nutrition segment.
As Jack Henry & Associates (JKHY) prepares to announce its fiscal fourth-quarter results, the financial technology sector watches closely. The report could set the tone for peers in a market segment recently under pressure.
Amid a brutal year for apparel stocks, Deckers Outdoor delivered a stunning earnings beat, sending shares soaring 19%. The performance of its HOKA and UGG brands, coupled with raised guidance, suggests Wall Street's pessimism may have been overblown for this long-term winner.
Shares of staffing giant Robert Half International surged nearly 28% in a single session, propelled by a significant price target increase from Truist Securities. The rally comes despite the company reporting a sharp decline in annual profits, highlighting a stark divergence between analyst confidence and recent financial performance.
The healthcare behemoth's robust 2025 results and 2026 guidance signal a landmark year ahead, as it navigates patent expirations and pricing pressures while maintaining its coveted dividend king status.
